CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Apr 18, 2025. (Total: 6642 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-9 (of 9 Records)

Query Trace: Cascade screening[original query]
Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA. Miller DM , Gaviglio A , Zierhut HA . Public Health Genomics 2021 24 1-13
Is universal tumor testing for Lynch syndrome cost-effective? It depends! Grosse SD . Genet Med 2018 21 (1) 252-253
Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing. Knowles JW , Rader DJ , Khoury MJ . JAMA 2017 318 (4) 381-382
Reducing the burden of disease and death from familial hypercholesterolemia: a call to action. Knowles JW , O'Brien EC , Greendale K , Wilemon K , Genest J , Sperling LS , Neal WA , Rader DJ , Khoury MJ . Am Heart J 2014 168 (6) 807-11
Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility. Grosse SD . Genet Med 2013 16 (3) 225-7
Modeling uncertain outcomes of genetic testing: factor V Leiden mutation and pregnant women. Grosse SD , Caughey AB . Genet Med 2013 15 (5) 335-7
Cascade Screening for Familial Hypercholesterolemia (FH). Ned RM , Sijbrands EJ . PLoS Curr 2011 3 Rrn1238
Evaluation of the validity and utility of genetic testing for rare diseases. Grosse SD , Kalman L , Khoury MJ . Adv Exp Med Biol 2010 686 115-31
Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Grosse SD , Rogowski WH , Ross LF , Cornel MC , Dondorp WJ , Khoury MJ . Public Health Genomics 2010 13 (2) 106-15